Neuberger Berman Group LLC Atai Life Sciences N.V. Transaction History
Neuberger Berman Group LLC
- $124 Billion
- Q2 2025
A detailed history of Neuberger Berman Group LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 10,700 shares of ATAI stock, worth $61,846. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,700
Previous 10,700
-0.0%
Holding current value
$61,846
Previous $23,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
115Shares Held
31.6MCall Options Held
494KPut Options Held
315K-
Ubs Group Ag7.7MShares$44.5 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$31.4 Million0.02% of portfolio
-
Morgan Stanley New York, NY3.49MShares$20.2 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.64MShares$15.3 Million0.59% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$7.55 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $959M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...